These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 1942242

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Essential role of NF-kappa B in transactivation of the human immunodeficiency virus long terminal repeat by the human cytomegalovirus 1E1 protein.
    Kim S, Yu SS, Kim VN.
    J Gen Virol; 1996 Jan; 77 ( Pt 1)():83-91. PubMed ID: 8558131
    [Abstract] [Full Text] [Related]

  • 23. TNF-alpha-mediated activation of HIV-1 LTR in monocytoid cells by mycobacteria.
    Kitaura H, Ohara N, Kobayashi K, Yamada T.
    FEMS Immunol Med Microbiol; 2001 Aug; 31(2):97-103. PubMed ID: 11549416
    [Abstract] [Full Text] [Related]

  • 24. Tumor necrosis factor alpha activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-kappa B sites in the long terminal repeat.
    Duh EJ, Maury WJ, Folks TM, Fauci AS, Rabson AB.
    Proc Natl Acad Sci U S A; 1989 Aug; 86(15):5974-8. PubMed ID: 2762307
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Inhibition of human immunodeficiency virus type 1 replication by a Tat-activated, transduced interferon gene: targeted expression to human immunodeficiency virus type 1-infected cells.
    Su Y, Popik W, Pitha PM.
    J Virol; 1995 Jan; 69(1):110-21. PubMed ID: 7983701
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Activation of the human immunodeficiency virus long terminal repeat in THP-1 cells by a staphylococcal extracellular product.
    Klebanoff SJ, Kazazi F, Van Voorhis WC, Schlechte KG.
    Proc Natl Acad Sci U S A; 1994 Oct 25; 91(22):10615-9. PubMed ID: 7938001
    [Abstract] [Full Text] [Related]

  • 29. Poly (ADP-ribose) polymerase is involved in PMA-induced activation of HIV-1 in U1 cells by modulating the LTR function.
    Kameoka M, Tanaka Y, Ota K, Itaya A, Yoshihara K.
    Biochem Biophys Res Commun; 1999 Aug 19; 262(1):285-9. PubMed ID: 10448106
    [Abstract] [Full Text] [Related]

  • 30. Inhibition of human immunodeficiency virus type 1 replication in vitro by a novel combination of anti-Tat single-chain intrabodies and NF-kappa B antagonists.
    Mhashilkar AM, Biswas DK, LaVecchio J, Pardee AB, Marasco WA.
    J Virol; 1997 Sep 19; 71(9):6486-94. PubMed ID: 9261367
    [Abstract] [Full Text] [Related]

  • 31. Replication of human immunodeficiency virus-1 in primary human T cells is dependent on the autocrine secretion of tumor necrosis factor through the control of nuclear factor-kappa B activation.
    Muñoz-Fernández MA, Navarro J, Garcia A, Punzón C, Fernández-Cruz E, Fresno M.
    J Allergy Clin Immunol; 1997 Dec 19; 100(6 Pt 1):838-45. PubMed ID: 9438495
    [Abstract] [Full Text] [Related]

  • 32. Regulation of NF-kappaB and HIV-1 LTR activity in mouse L cells by ultraviolet radiation: LTR trans-activation in a nonirradiated genome in heterokaryons.
    Miller SC, Taylor A, Watanabe K, Mok K, Torti FM.
    Exp Cell Res; 1997 Jan 10; 230(1):9-21. PubMed ID: 9013701
    [Abstract] [Full Text] [Related]

  • 33. The Epstein-Barr virus DNA polymerase transactivates the human immunodeficiency virus type 1 5' long terminal repeat.
    Lin JC.
    Biochem Biophys Res Commun; 1993 Aug 31; 195(1):242-9. PubMed ID: 8395825
    [Abstract] [Full Text] [Related]

  • 34. CD8+ T cell supernatants of HIV type 1-infected individuals have opposite effects on long terminal repeat-mediated transcription in T cells and monocytes.
    Copeland KF, Leith JG, McKay PJ, Rosenthal KL.
    AIDS Res Hum Retroviruses; 1997 Jan 01; 13(1):71-7. PubMed ID: 8989429
    [Abstract] [Full Text] [Related]

  • 35. Interleukin 1 induces HIV-1 expression in chronically infected U1 cells: blockade by interleukin 1 receptor antagonist and tumor necrosis factor binding protein type 1.
    Granowitz EV, Saget BM, Wang MZ, Dinarello CA, Skolnik PR.
    Mol Med; 1995 Sep 01; 1(6):667-77. PubMed ID: 8529133
    [Abstract] [Full Text] [Related]

  • 36. Synergistic activation of human immunodeficiency virus type 1 promoter activity by NF-kappaB and inhibitors of deacetylases: potential perspectives for the development of therapeutic strategies.
    Quivy V, Adam E, Collette Y, Demonte D, Chariot A, Vanhulle C, Berkhout B, Castellano R, de Launoit Y, Burny A, Piette J, Bours V, Van Lint C.
    J Virol; 2002 Nov 01; 76(21):11091-103. PubMed ID: 12368351
    [Abstract] [Full Text] [Related]

  • 37. Latency-associated nuclear antigen encoded by Kaposi's sarcoma-associated herpesvirus interacts with Tat and activates the long terminal repeat of human immunodeficiency virus type 1 in human cells.
    Hyun TS, Subramanian C, Cotter MA, Thomas RA, Robertson ES.
    J Virol; 2001 Sep 01; 75(18):8761-71. PubMed ID: 11507221
    [Abstract] [Full Text] [Related]

  • 38. Identification of c-fos-responsive elements downstream of TAR in the long terminal repeat of human immunodeficiency virus type-1.
    Roebuck KA, Brenner DA, Kagnoff MF.
    J Clin Invest; 1993 Sep 01; 92(3):1336-48. PubMed ID: 8376588
    [Abstract] [Full Text] [Related]

  • 39. Dual activity of pyrrolidine dithiocarbamate on kappaB-dependent gene expression in U937 cells: II. Regulation by tumour necrosis factor-alpha.
    Watanabe K, Kazakova I, Furniss M, Miller SC.
    Cell Signal; 1999 May 01; 11(5):371-83. PubMed ID: 10376811
    [Abstract] [Full Text] [Related]

  • 40. Activating protein-1 cooperates with phorbol ester activation signals to increase HIV-1 expression.
    Roebuck KA, Gu DS, Kagnoff MF.
    AIDS; 1996 Jul 01; 10(8):819-26. PubMed ID: 8828738
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.